Covered recipient · General Payments record
VICKY K PARKER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,000.23
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $338.04 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $106.61 | 5 |
| PFIZER INC. | $65.01 | 4 |
| Phathom Pharmaceuticals, Inc. | $37.20 | 2 |
| Acerta Pharma LLC | $37.13 | 2 |
| DEXCOM, INC. | $26.96 | 1 |
| Astellas Pharma US Inc | $18.45 | 1 |
| Alkermes, Inc. | $17.91 | 1 |
| Amgen Inc. | $15.42 | 1 |
| Abbott Laboratories | $13.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.35 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124994020 | CMS |
| ABBVIE INC. | $23.06 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107791827 | CMS |
| ABBVIE INC. | $21.72 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107791831 | CMS |
| ABBVIE INC. | $19.60 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107791836 | CMS |
| ABBVIE INC. | $22.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107791840 | CMS |
| ABBVIE INC. | $20.23 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107791845 | CMS |
| Alkermes, Inc. | $17.91 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120570079 | CMS |
| Amgen Inc. | $15.42 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117347162 | CMS |
| Astellas Pharma US Inc | $18.45 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139532674 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.77 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104471386 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.36 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104626602 | CMS |
| Dexcom, Inc. | $26.96 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153391302 | CMS |
| PFIZER INC. | $13.77 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131231109 | CMS |
| PFIZER INC. | $16.07 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131646256 | CMS |
| PFIZER INC. | $15.68 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131776085 | CMS |
| PFIZER INC. | $19.49 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131867620 | CMS |
| Phathom Pharmaceuticals, Inc. | $21.87 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151195059 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.33 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151195061 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.